Journal article
Prognostic Factors and Outcomes After Definitive Treatment of Female Urethral Cancer: A Population-based Analysis
Urology (Ridgewood, N.J.), v 80(2), pp 374-382
01 Aug 2012
PMID: 22857759
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
To evaluate the prognostic factors and outcomes for a large observational cohort of female patients with urethral cancer in the Surveillance, Epidemiology, and End Results database.
We identified 722 women diagnosed with urethral cancer from 1983 to 2008 in the Surveillance, Epidemiology, and End Results database. Descriptive statistics were used to explore the epidemiology, standard treatment practices, and tumor characteristics. A total of 359 women with nonmetastatic primary urethral cancer were identified for cancer-specific and survival analysis. Kaplan-Meier plots and log-rank tests were performed for each potential covariate. A multivariate Cox proportional hazards model was performed to evaluate age, demographic factors, T stage, nodal status, histologic findings, surgery, and radiotherapy.
The median overall survival time was 42 months (95% confidence interval 35-57), and the 5- and 10-year overall survival rate was 43% and 32%, respectively. The median cancer-specific survival (CSS) time was 78 months, and the 5- and 10-year CSS rate was 53% and 46%, respectively. On multivariate analysis, black race, Stage T3-T4 tumors compared with T1, node-positive disease, nonsquamous histologic features, and advanced age were associated with shortened CSS. Surgery was associated with longer CSS. Black patients presented with a statistically significant greater T stage.
Advanced age, T stage, node-positive disease, nonsquamous histologic features, and black race were associated with reduced CSS, and surgical resection was associated with longer CSS. We found that black patients present with more advanced tumors and have shorter CSS than white women with urethral cancer.
Metrics
Details
- Title
- Prognostic Factors and Outcomes After Definitive Treatment of Female Urethral Cancer: A Population-based Analysis
- Creators
- Colin E. Champ - Thomas Jefferson UniversitySarah E. Hegarty - Thomas Jefferson UniversityXinglei Shen - Thomas Jefferson UniversityMark V. Mishra - Thomas Jefferson UniversityAdam P. Dicker - Thomas Jefferson UniversityEdouard J. Trabulsi - Thomas Jefferson UniversityCostas D. Lallas - Thomas Jefferson UniversityLeonard G. Gomella - Thomas Jefferson UniversityTerry Hyslop - Thomas Jefferson UniversityTimothy N. Showalter - Thomas Jefferson University
- Publication Details
- Urology (Ridgewood, N.J.), v 80(2), pp 374-382
- Publisher
- Elsevier
- Grant note
- P30 CA56036 / Kimmel Cancer Center's National Cancer Institute Cancer Center
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:000307244200046
- Scopus ID
- 2-s2.0-84864575592
- Other Identifier
- 991021897389904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Urology & Nephrology